General Information of the Compound
Compound ID
CP0492215
Compound Name
N-benzyl-4-[(2,5-dihydroxyphenyl)methylamino]benzamide
    Show/Hide
Synonyms
BDBM50102429
CHEMBL343071
N-Benzyl-4-(2,5-dihydroxy-benzylamino)-benzamide
    Show/Hide
Structure
Formula
C21H20N2O3
Molecular Weight
348.402
Canonical SMILES
Oc1ccc(O)c(CNc2ccc(cc2)C(=O)NCc2ccccc2)c1
    Show/Hide
InChI
InChI=1S/C21H20N2O3/c24-19-10-11-20(25)17(12-19)14-22-18-8-6-16(7-9-18)21(26)23-13-15-4-2-1-3-5-15/h1-12,22,24-25H,13-14H2,(H,23,26)
    Show/Hide
InChIKey
QQMFNDVDKBSOEC-UHFFFAOYSA-N
Physicochemical Property
logP
3.6399
Rotatable Bonds
6
Heavy Atom Count
26
Polar Areas
81.59
Hydrogen Bond Donor Count
4
Hydrogen Bond Acceptor Count
4
Complexity
26

"RO5" indicates the cutoff set by lipinski's rule of five:

(1) Molecular weight less than 500 Dalton;

(2) xlogp less than 5;

(3) No more than 5 hbonddonor (Hydrogen Bond Donor Count);

(4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count);

(5) No more than 10 rotbonds (Rotatable Bond Count).

    Show/Hide
Click to Show/Hide the External Link(s) of This Compound
PubChem ID
CID: 10593843
SID: 15622985
ChEMBL ID
CHEMBL343071
Map of Molecular Bioactivity Related to the Compound
Map of Molecular Bioactivity Related to the Compound

Compound
Cell Line
Protein

Bioactivity Value:

<= 0.1 μM
> 0.1 μM and <= 10 μM
> 10 μM
Imprecise Activity
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT01605, Epidermal growth factor receptor
Cell-based Assay
Cell Line ID Cell Line Name Cell Line Organism
CL000077 Ba/F3 Mus musculus (Mouse)  1
1
IC50 > 100000 nM
   TI
   LI
   LO
   TS
Cell Viability or Cytotoxicity Assay
Cell Line ID Cell Line Name Cell Line Organism
CL000067 HCT 116 Homo sapiens (Human)  1
1
GI50 = 10000 nM
   TI
   LI
   LO
   TS
CL000112 MDA-MB-435 Homo sapiens (Human)  1
1
GI50 = 12000 nM
   TI
   LI
   LO
   TS
CL000307 SN12C Homo sapiens (Human)  1
1
GI50 = 9700 nM
   TI
   LI
   LO
   TS
Clinical Information about the Compound
Drug 1 ( N-Benzyl-4-(2,5-dihydroxy-benzylamino)-benzamide )
Drug Name N-Benzyl-4-(2,5-dihydroxy-benzylamino)-benzamide
Target(s)
Tyrosine-protein kinase SYK (SYK)
Inhibitor